Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), has reported selling shares of common stock on February 3rd and 4th, 2025.

Summary

• Saba Capital Management, L.P., a significant shareholder of BlackRock Capital Allocation Term Trust (BCAT), filed a Form 4 detailing changes in their beneficial ownership.
• On February 3, 2025, Saba Capital sold 35,272 shares of BCAT common stock at a price of $15.46 per share.
• Following this transaction, Saba Capital's indirect ownership amounted to 13,366,970 shares.
• On February 4, 2025, Saba Capital sold 25,108 shares of BCAT common stock at a price of $15.55 per share.
• Following this transaction, Saba Capital's indirect ownership amounted to 13,341,862 shares.
• Boaz Weinstein, also listed as a reporting person, is associated with Saba Capital Management.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative as a large shareholder is reducing their position, which could indicate a lack of confidence or a strategic portfolio shift. However, the sales are relatively small compared to their overall holdings.

Negatives

• Saba Capital Management reduced its holdings in BlackRock Capital Allocation Term Trust (BCAT).

Risks

• Continued selling pressure from Saba Capital could negatively impact BCAT's stock price.

Industry Context

Hedge funds like Saba Capital Management frequently adjust their positions in publicly traded companies, especially closed-end funds like BCAT, to manage their portfolios and capitalize on market opportunities.

Stakeholder Impact

• Shareholders of BCAT may experience slight downward pressure on the stock price due to the sale of shares by Saba Capital.

Key Dates

Keywords

Saba Capital Management, BlackRock Capital Allocation Term Trust, BCAT, Form 4, Beneficial Ownership, Share Sale, Weinstein, Gindes